RHODOTORULA SPECIES AS AN EMERGING OPPORTUNISTIC PATHOGEN

Nida tabassum khan

doi:10.37547/tajas/Volume04Issue06-02

RHODOTORULA SPECIES AS AN EMERGING OPPORTUNISTIC PATHOGEN

HAC

inLibrary

Google Scholar

doi

2022-06-20

Journal:

The American Journal of Applied sciences

Issue:

No. 06 (2022)

Nida tabassum khan

Department of Biotechnology, Faculty of Life Sciences & Informatics, Balochistan University of Information Technology, Engineering and Management Sciences, Takatu Campus, Airport Road, Quetta, Balochistan Pakistan

dfddf@orientalresearch.uz

doi

https://doi.org/10.37547/tajas/Volume04Issue06-02

CC BY f

5-9

To share

Download

Article on Google Scholar

Nida tabassum khan, . (2022). RHODOTORULA SPECIES AS AN EMERGING OPPORTUNISTIC PATHOGEN. The American Journal of Applied Sciences, 4(06), 5–9. https://doi.org/10.37547/tajas/Volume04Issue06-02

Citations

Сrossref

Scopus

Google

Keywords:

Venous catheters / Meningitis / Rhodotorula glutinis / Endophthalmitis

Abstract

Rhodotorula species, part of the Basidiomycota phylum, is a typical ecological yeast that is found in air, soil, lakes, sea water, and natural product juice. colonize plants, people, and different vertebrates. The class Rhodotorula incorporates eight species, of which Rhodotorula mucilaginosa, Rhodotorula glutinis, and Rhodotorula minuta are human pathogens. It produces pink to red colonies and possess unicellular blastoconidia that lacks pseudohyphae and hyphae. Rhodotorula spp. have been perceived as arising yeast pathogen in humans over the most recent twenty years. While no instances of Rhodotorula disease were accounted for in the clinical writing before 1985, the cases expanded after that time, no doubt in light of the more extensive utilization of serious medicines and focal venous catheters.

References

Wirth, F., & Goldani, L. Z. (2012). Epidemiology of Rhodotorula: an emerging pathogen. Interdisciplinary perspectives on infectious diseases, 2012.

Tuon, F. F., & Costa, S. F. (2008). Rhodotorula infection. A systematic review of 128 cases from literature. Rev Iberoam Micol, 25(3), 135-40.

Zaas, A. K., Boyce, M., Schell, W., Lodge, B. A., Miller, J. L., & Perfect, J. R. (2003). Risk of fungemia due to Rhodotorula and antifungal susceptibility testing of Rhodotorula isolates. Journal of Clinical Microbiology, 41(11), 5233-5235.

Lunardi, L. W., Aquino, V. R., Zimerman, R. A., & Goldani, L. Z. (2006). Epidemiology and outcome of Rhodotorula fungemia in a tertiary care hospital. Clinical Infectious Diseases, 43(6), e60-e63.

Wirth, F., & Goldani, L. Z. (2012). Epidemiology of Rhodotorula: an emerging pathogen. Interdisciplinary perspectives on infectious diseases, 2012.

García‐Suárez, J., Gómez‐Herruz, P., Cuadros, J. A., & Burgaleta, C. (2011). Epidemiology and outcome of Rhodotorula infection in haematological patients. Mycoses, 54(4), 318-324.

Ioannou, P., Vamvoukaki, R., & Samonis, G. (2019). Rhodotorula species infections in humans: A systematic review. Mycoses, 62(2), 90-100.

Potenza, L., Chitasombat, M. N., Klimko, N., Bettelli, F., Dragonetti, G., Del Principe, M. I., ... & Pagano, L. (2019). Rhodotorula infection in haematological patient: risk factors and outcome. Mycoses, 62(3), 223-229.

Rusthoven, J. J., Feld, R., & Tuffnell, P. G. (1984). Systemic infection by Rhodotorula spp. in the immunocompromised host. Journal of infection, 8(3), 241-246.

Spiliopoulou, A., Anastassiou, E. D., & Christofidou, M. (2012). Rhodotorula fungemia of an intensive care unit patient and review of published cases. Mycopathologia, 174(4), 301-309.

Duboc De Almeida, G. M., Figueiredo Costa, S., Melhem, M., Motta, A. L., Walderez Szeszs, M., Miyashita, F., ... & Burattini, M. N. (2008). Rhodotorula spp. isolated from blood cultures: clinical and microbiological aspects. Sabouraudia, 46(6), 547-556.

Seifi, Z., Mahmoudabadi, A. Z., & Hydrinia, S. (2013). Isolation, identification and susceptibility profile of Rhodotorula species isolated from two educational hospitals in Ahvaz. Jundishapur Journal of Microbiology, 6(6), 1I.

MANTADAKIS, M. A. E., & GALANAKIS, E. (2003). Rhodotorula species fungemia: a threat to the immunocompromised host. Clin. Lab, 49, 49-55.

Diekema, D. J., Petroelje, B., Messer, S. A., Hollis, R. J., & Pfaller, M. A. (2005). Activities of available and investigational antifungal agents against Rhodotorula species. Journal of clinical microbiology, 43(1), 476-478.

El-Tahawy, A. T., & Khalaf, R. M. (1999). Rhodotorula rubra fungemia in an immunocompromised patient. Annals of Saudi medicine, 19(6), 533-535.

Rajmane, V. S., Rajmane, S. T., & Ghatole, M. P. (2011). Rhodotorula species infection in traumatic keratitis—a case report. Diagnostic microbiology and infectious disease, 71(4), 428-429.

Merkur, A. B., & Hodge, W. G. (2002). Rhodotorula rubra endophthalmitis in an HIV positive patient. British Journal of Ophthalmology, 86(12), 1444-1445.

Miceli, M. H., Díaz, J. A., & Lee, S. A. (2011). Emerging opportunistic yeast infections. The Lancet infectious diseases, 11(2), 142-151.

Baradkar, V. P., & Kumar, S. (2008). Meningitis caused by Rhodotorula mucilaginosa in human immunodeficiency virus seropositive patient. Annals of Indian Academy of Neurology, 11(4), 245.

Tuon, F. F., Duboc de Almeida, G. M., & Costa, S. F. (2007). Central venous catheter-associated fungemia due to Rhodotorula spp.–a systematic review. Sabouraudia, 45(5), 441-447.

Simon, M. S., Somersan, S., Singh, H. K., Hartman, B., Wickes, B. L., Jenkins, S. G., ... & Schuetz, A. N. (2014). Endocarditis caused by Rhodotorula infection. Journal of clinical microbiology, 52(1), 374-378.

Menon, S., Gupta, H. R., Sequeira, R., Chavan, S., Gholape, D., Amandeep, S., ... & Chowdhary, A. S. (2014). Rhodotorula glutinis meningitis: a case report and review of literature. Mycoses, 57(7), 447-451.

Lin, L., & Xu, J. (2020). Fungal pigments and their roles associated with human health. Journal of Fungi, 6(4), 280.

Crich, D., Li, W., & Li, H. (2004). Direct Chemical Synthesis of the β-Mannans: Linear and Block Syntheses of the Alternating β-(1→ 3)-β-(1→ 4)-Mannan Common to Rhodotorula glutinis, Rhodotorula mucilaginosa, and Leptospira biflexa. Journal of the American Chemical Society, 126(46), 15081-15086.

Tulloch, A. P., & Spencer, J. F. T. (1964). Extracellular glycolipids of Rhodotorula species: the isolation and synthesis of 3-d-hydroxypalmitic and 3-d-hydroxystearic acids. Canadian Journal of Chemistry, 42(4), 830-835.

Kot, A. M., Błażejak, S., Gientka, I., Kieliszek, M., & Bryś, J. (2018). Torulene and torularhodin:“new” fungal carotenoids for industry?. Microbial Cell Factories, 17(1), 1-14.

Onishi, N., & Tanaka, T. (1996). Purification and properties of a galacto-and gluco-oligosaccharide-producing β-glycosidase from Rhodotorula minuta IFO879. Journal of fermentation and bioengineering, 82(5), 439-443.

P de Carvalho, M., & Abraham, W. R. (2012). Antimicrobial and biofilm inhibiting diketopiperazines. Current medicinal chemistry, 19(21), 3564-3577.

Anwar, M. M., El-Haggar, R. S., & Zaghary, W. A. (2015). Salmeterol xinafoate. Profiles of Drug Substances, Excipients and Related Methodology, 40, 321-369.

Cazzola, M., Testi, R., & Matera, M. G. (2002). Clinical pharmacokinetics of salmeterol. Clinical pharmacokinetics, 41(1), 19-30.

Bonadio, M. D. P., Freita, L. A. D., & Mutton, M. J. R. (2018). Carotenoid production in sugarcane juice and synthetic media supplemented with nutrients by Rhodotorula rubra l02. brazilian journal of microbiology, 49, 872-878.